Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The paracrine signaling factors released by adipose tissue-derived mesenchymal stromal/stem cells (AD-MSCs) constitute a complex mixture of bioactive proteins, cytokines, chemokines, growth factors, and extracellular vesicles collectively referred to as the AD-MSC secretome. Rather than acting through direct cell replacement, AD-MSCs mediate most of their tissue regenerative and immunomodulatory actions via secretion of these paracrine factors. They have been shown to promote angiogenesis, suppress inflammation, enhance tissue repair, and support cell survival in various disease contexts including osteoarthritis, cardiac injury, and general tissue injury. However, as a target, this mixture is not a discrete molecular entity and thus does not meet strict criteria for a classic therapeutic target such as a receptor or enzyme[2][3][4][1]. This is not a single molecular target but a functional collection of secreted products. Commonly identified factors in the secretome include VEGF, HGF, FGF2, IGF-1, IL-6, and TGF-β1[3][4][6]. AD-MSC secretome is actively researched for regenerative and immunomodulatory medicine due to its multifaceted mechanisms[3][4]. No approved drugs directly target "AD-MSC paracrine factors" as a molecular target; research focuses on harnessing or mimicking the secretome's effects[4]. Safety and efficacy are active concerns due to biological variability and challenges in component standardization[4]. This entity should not be categorized as a classical drug target; instead, it's a functional biological product under investigation for cell-free regenerative medicine approaches.
Paracrine modulation of immune and tissue microenvironments; Secretion of protective factors (e.g., VEGF, HGF, FGF2, IGF1, IL-6, TGF-β1)[3][4][6]; Release of extracellular vesicles and exosomes carrying bioactive molecules[3][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine signaling factors released by adipose tissue-derived mesenchymal stromal cells.